Cargando…
Novel Advances in Modifying BMPR2 Signaling in PAH
Pulmonary Arterial Hypertension (PAH) is a disease of the pulmonary arteries, that is characterized by progressive narrowing of the pulmonary arterial lumen and increased pulmonary vascular resistance, ultimately leading to right ventricular dysfunction, heart failure and premature death. Current tr...
Autores principales: | Dannewitz Prosseda, Svenja, Ali, Md Khadem, Spiekerkoetter, Edda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824173/ https://www.ncbi.nlm.nih.gov/pubmed/33374819 http://dx.doi.org/10.3390/genes12010008 |
Ejemplares similares
-
Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2020) -
PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Ali, Md Khadem, et al.
Publicado: (2023) -
Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2018) -
Decreasing ELK3 expression improves Bone Morphogenetic Protein Receptor 2 signaling and pulmonary vascular cell function in PAH
por: Ali, Md Khadem, et al.
Publicado: (2023) -
TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
por: Rol, Nina, et al.
Publicado: (2018)